10:11 AM EST - Willow Biosciences Inc. : Announces a multi-product development and licensing partnership with Laurus Labs, a leading research-driven pharmaceutical and biotechnology company with a $3.9 billion market cap that serves global pharmaceutical companies and offers CDMO services. Willow Biosciences Inc.
shares T.WLLW are trading up $0.02 at $0.10.
